COVID-19 kick-starts a new era for clinical trials and pandemic preparedness in Europe.

Szepessy, Edit; Arlett, Peter; Sweeney, Fergus; Broich, Karl; Rys, Andrzej Jan

Szepessy, Edit; Arlett, Peter; Sweeney, Fergus; Broich, Karl; Rys, Andrzej Jan.

Szepessy E; European Commission, Brussels, Belgium. Electronic address: edit.szepessy@ec.europa.eu.
Arlett P; European Medicines Agency, Amsterdam, Netherlands.
Sweeney F; European Medicines Agency, Amsterdam, Netherlands.
Broich K; Bundesinstitut fur Arzneimittel und Medizinprodukte, Bonn, Germany.
Rys AJ; European Commission, Brussels, Belgium.

Lancet Infect Dis ; 22(3): 315-316, 2022 03.

Article in English | MEDLINE | ID: covidwho-1700578

Subject(s)

COVID-19; Cooperative Behavior; Financing, Government/economics; Pandemics/prevention & control; Research; Clinical Trials as Topic; Europe; Humans; Public Health; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Research / Cooperative Behavior / Pandemics / Financing, Government / COVID-19 Type of study: Prognostic study / Randomized controlled trials Limits: Humans Country/Region as subject: Europa Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google